however, they also show that skin-related adverse events do occur and may be underrecognized in clinical practice, Fat told Healio
In fact, the study's authors cautioned that weed should not be relied upon as a weight loss aid
Min T, Bain SC (2021) The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
Apoptosis 23:679694 Regina A, Demeule M, Che C, Lavallee I, Poirier J, Gabathuler R, Bliveau R, Castaigne JP (2008) Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2
Key Comparative Insight Mounjaro generally delivers greater average weight loss (around ~23%) compared to Wegovys ~18% at current doses, but Wegovys upcoming 7.2 mg dose may match or even exceed that, with early trial data showing ~21% loss, and a third of patients losing more than 25% Pricing: UK Private Market Spotlight Mounjaro As of 1 September 2025 , UK private prices for the highest dose surged from ~122 to between 270330 per month , a dramatic increase of up to 170% Wegovy Remains considerably more affordable , with private monthly fees typically ranging between 85240 , depending on dose and provider Novo Nordisk has confirmed no planned price increases in the UK Switching: Tips for a Seamless Transition Dosage Alignment : Healthcare providers can match your current Mounjaro dose to an equivalent Wegovy dose (e.g., if you experienced side effects on Mounjaro, they may advise stepping down slightly on Wegovy initially) Avoiding Dual Use : Never take both medications simultaneously doing so increases side effect risks without improving results
How do they work together in the body
